We are glad to share that BCGene participated in the FAPESP-Week China, to celebrate the 50 years anniversary of diplomatic relations between Brazil and China. We had the opportunity not only to visit very well-established companies, such as BGI Group, and discuss possible future collaborations, but also start-ups from the area. We had very fruitful discussions on possible collaborations with Maxvax Biotechnology, a company with promising new vaccines and adjuvants in clinical trials. Additionally, we had productive discussions with the Almatech Group, dedicated to expansion and integration of biotech companies in the Great Bay Area based on a deep understanding of European and Chinese markets. On a whole, several promising contacts were established.
BCGene
Pesquisa biotecnológica
São Paulo, sp 226 seguidores
Pioreering in recombinant BCG technology
Sobre nós
Advanced technology for development of products based on recombinant BCG as Vaccines and Cancer Therapy A partnership with Instituto Butantan
- Site
-
www.bcgene.com.br
Link externo para BCGene
- Setor
- Pesquisa biotecnológica
- Tamanho da empresa
- 2-10 funcionários
- Sede
- São Paulo, sp
- Tipo
- Empresa privada
- Fundada em
- 2021
- Especializações
- Product development
Localidades
-
Principal
Como chegar
Av. Brigadeiro Faria Lima 3441
Suite 31
São Paulo, sp 04538-132, BR
Funcionários da BCGene
Atualizações
-
We are glad to share the participation of BCGene in the Day of Italy at FAPESP. It was as important meeting to promote new collaborations and strengthen partnerships between Italy and Brazil. Several spin-offs from University were represented. BCGene, as spin-off from Instituto Butantan presented its proposal for the development of new vaccines against tuberculosis.
-